BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6757638)

  • 21. A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia.
    Thienhaus OJ; Wheeler BG; Simon S; Zemlan FP; Hartford JT
    J Am Geriatr Soc; 1987 Mar; 35(3):219-23. PubMed ID: 3819261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
    van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
    J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly.
    Gross RJ; Eisdorfer CE; Schiller HS; Cox G
    Exp Aging Res; 1979 Aug; 5(4):293-302. PubMed ID: 520386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydergine in senile mental impairment.
    Loew DM; Weil C
    Gerontology; 1982; 28(1):54-74. PubMed ID: 7037548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
    Dartigues JF; Père JJ
    Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experiences with Card-hydergine in patients with cardiac insufficiency and cerebrovascular disorders in professional practice].
    Kohler H
    Med Monatsschr; 1976 Nov; 30(11):516-8. PubMed ID: 792670
    [No Abstract]   [Full Text] [Related]  

  • 27. Hydergine and cyclosporin nephrotoxicity.
    Nussenblatt RB; Austin HA; Palestine AG; Preuss HG
    Lancet; 1986 May; 1(8491):1220-1. PubMed ID: 2871464
    [No Abstract]   [Full Text] [Related]  

  • 28. Review of clinical studies with ergots in gerontology.
    Venn RD
    Adv Biochem Psychopharmacol; 1980; 23():363-77. PubMed ID: 7395623
    [No Abstract]   [Full Text] [Related]  

  • 29. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 30. Relieving select symptoms of the elderly.
    Nelson JJ
    Geriatrics; 1975 Mar; 30(3):133-9, 142. PubMed ID: 803912
    [No Abstract]   [Full Text] [Related]  

  • 31. [Double blind test of hydergine in the aged].
    Bargheon J
    Nouv Presse Med; 1973 Sep; 2(31):2053-5. PubMed ID: 4199834
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical evaluation of a new preparation of Ersilan drops in patients with vascular headaches].
    Serclová L
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(5):649-55. PubMed ID: 3155391
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of Hydergine on neurotransmitters.
    Ermini M
    Br J Clin Pract Suppl; 1985 Jun; 39():11-5. PubMed ID: 2864053
    [No Abstract]   [Full Text] [Related]  

  • 34. Co-dergocrine mesylate (Hydergine) and hypertensive emergencies.
    Romero R; Felip A; Llibre JM; Bonet J; Caralps A
    Nephron; 1989; 51(1):127-8. PubMed ID: 2915745
    [No Abstract]   [Full Text] [Related]  

  • 35. Sinus bradycardia following treatment with hydergine for cerebrovascular insufficiency.
    Dcayley AC; Macpherson A; Wedgwood J
    Br Med J; 1975 Nov; 4(5993):384-5. PubMed ID: 811310
    [No Abstract]   [Full Text] [Related]  

  • 36. A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
    Thibault A
    Curr Med Res Opin; 1974; 2(8):482-7. PubMed ID: 4217240
    [No Abstract]   [Full Text] [Related]  

  • 37. [A new dihydroergotoxine preparation for hypertension in the aged. Study of effectiveness and tolerance in a placebo-controlled trial].
    Schuback G; Rogalla K
    Fortschr Med; 1987 Oct; 105(31):617-20. PubMed ID: 3319850
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of twice standard dosage of neuroactive drugs in dementia. A preliminary report.
    Knox J; Hindmarch I; Wallace M
    Br J Clin Pract; 1984 Sep; 38(9):313-5. PubMed ID: 6477811
    [No Abstract]   [Full Text] [Related]  

  • 39. [Controlled clinical study on the activity and tolerance of Trivastan].
    Nicrosini F; Pasotti C
    Minerva Med; 1976 May; 67(26):1745-50. PubMed ID: 778674
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypertension in old age. Treatment with Hydergin].
    Dennler HJ; Weidinger G
    ZFA (Stuttgart); 1983 Oct; 59(29):1646-9. PubMed ID: 6359752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.